Skip to main content
Fig. 5 | Arthritis Research & Therapy

Fig. 5

From: Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL/lpr mice

Fig. 5

The differences in the side effects of prednisone among MT, Pred, and FMT groups. a Liver total superoxide dismutase (T-SOD) activity. b Liver CuZn superoxide dismutase (CuZn-SOD) activity. c Liver malonaldehyde (MDA) concentration. d Liver IL-6 concentration. e Liver TNF-α concentration. f Serum cholesterol (CHOL) concentration. g Tibial bone mineral density (BMD). MT, the MRL/lpr mice treated with sterile water; Pred, the MRL/lpr mice treated with prednisone; FMT, the MRL/lpr mice treated with fecal microbiota transplantation. “**” represents p < 0.01; “*” represents p < 0.05; “ns” represents no significant difference

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us